>PA918075.1 JP 2019517471-A/4: A Composition and Method of Using miR-302 Precursors as Anti-Cancer Drugs for Treating Human Lung Cancers
CCACCACTTAAACGTGGATGTACTTGCTTTGAAACTAAAGAAGTAAGTGCTTCCATGTTTTGGTGATGG
>NR_126584.1 Oryctolagus cuniculus microRNA mir-302a (MIR302A), microRNA
CCACCACTTAAACGTGGATGTACTTGCTTTGAAACTAAAAAAGTAAGTGCTTCCATGTTTTGGTGATGG
>NR_049443.1 Canis lupus familiaris microRNA mir-302a (MIR302A), microRNA
CCACCACTTAAACGTGGATGTACTTGCTTTGAAACTCAAAAAGTAAGTGCTTCCATGTTTTAGTGATGG
>NR_029653.1 Mus musculus microRNA 302a (Mir302a), microRNA
CCACCACTTAAACGTGGTTGTACTTGCTTTAGACCTAAGAAAGTAAGTGCTTCCATGTTTTGGTGATGG
